Standardized Method for Quantitative Assessment of the Efficacy of Bone-Targeted Radionuclide Therapy with Radium-223 Chloride in Patients with Prostate Cancer.

Read full text Summarise with VIRAT
Authors: Е. А. Николаева, Alexander S. Krylov, Alexey D. Ryzhkov, Sergey Prokhorov
Cited by: 0
References: 17

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction : Radium-223 (²²³Ra) therapy improves survival in patients with metastatic castration-resistant prostate cancer (mCRPC), but response monitoring is challenging due to the lack of classic PSA response. Standardized assessment methods based on imaging are needed. Objective : To develop and evaluate a comprehensive diagnostic algorithm for quantitative monitoring of the efficacy of ²²³Ra therapy based on SPECT/CT and bone scintigraphy data. Materials and Methods : A prospective single-center study included 114 mCRPC patients who received 2 to 6 injections of ²²³Ra. All patients underwent planar bone scintigraphy with automated Bone Scan Index (aBSI) calculation, quantitative SPECT/CT with standardized uptake value (SUV max , SUV mean ) and percent injected dose (%ID) calculation, PSMA-ligand PET/CT, assessment of biochemical markers (PSA, LDH, ALP) and clinical status. Results : In patients who completed the full course (6 injections, n = 64), a statistically significant decrease in all quantitative parameters was revealed: SUV max (from 51.9 ± 16.4 to 30.5 ± 11.2; p < 0.001), SUV mean (from 2.87 ± 0.63 to 2.43 ± 0.58; p = 0.021), %ID (from 12.4 ± 3.1 to 10.8 ± 2.6; p = 0.037), aBSI (from 2.15 ± 0.38 to 1.70 ± 0.31; p = 0.005), as well as levels of PSA, LDH and ALP. Imaging parameters significantly correlated with ALP levels, pain syndrome, functional status, and the development of hematological toxicity. High baseline SUV mean , %ID, and aBSI values were associated with an increased risk of myelosuppression. Conclusion : Quantitative SPECT/CT parameters (SUV max , SUV mean , %ID) and scintigraphy parameters (aBSI) are objective markers of the efficacy of ²²³Ra therapy, reflecting the dynamics of the metabolic activity of bone metastases and allowing to predict the development of hematological toxicity. A comprehensive multiparameter approach improves the accuracy of treatment response assessment.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Bone health and treatments

Publication details

Journal / source
Journal of oncology diagnostic radiology and radiotherapy
Volume
9
Issue
1
Pages
24–32
Publication date
28 March 2026
Language
EN